The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

Share Price Information for Centaur (CAU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.50
Bid: 50.00
Ask: 53.00
Change: 0.50 (0.98%)
Spread: 3.00 (6.00%)
Open: 51.00
High: 51.50
Low: 49.20
Prev. Close: 51.00
CAU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Centaur Media plc

11 Apr 2024 15:15

Aberforth Partners LLP - Form 8 (OPD) - Centaur Media plc

Aberforth Partners LLP - Form 8 (OPD) - Centaur Media plc

PR Newswire

LONDON, United Kingdom, April 11

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Aberforth Partners LLP, on behalf of discretionary clients.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

 

Centaur Media plc

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

 

10/04/2024

 

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

YES / NO / N/A NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

Ordinary Shares

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 33,717,126

 

22.959%

 

 

0

 

0.0

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

 33,717,126

 

22.959%

 

 

0

 

0.0

 

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 10,824,451 shares included in the total disclosed above. This total includes 10,824,451 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

N/A- Opening Disclosure

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

 

11 April 2024

 

Contact name:

Michael Campbell, for Aberforth Partners LLP

Telephone number:

0131 220 0733

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 



Date   Source Headline
29th Apr 202410:22 amRNSForm 8.5 (EPT/RI)
26th Apr 202411:37 amRNSForm 8.5 (EPT/RI)
25th Apr 202411:46 amRNSForm 8.5 (EPT/RI)
24th Apr 20249:39 amRNSForm 8.5 (EPT/RI)
23rd Apr 20247:00 amRNSCapital Markets Day 2024
22nd Apr 20246:25 pmRNSAmendment to previous Form 8
22nd Apr 20247:02 amRNSAppointment of new Managing Director at The Lawyer
19th Apr 20246:20 pmRNSForm 8 (OPD) (Centaur Media plc)
19th Apr 20246:20 pmRNSTechnical Amendment
19th Apr 20245:10 pmRNSForm 8.3 - Centaur Media plc
19th Apr 202410:47 amRNSForm 8.5 (EPT/RI)
18th Apr 20249:00 amRNSDirector/PDMR Shareholding
16th Apr 20241:43 pmGNWForm 8.3 - Centaur Media Plc
16th Apr 20249:40 amRNSForm 8.5 (EPT/RI)
15th Apr 202410:15 amRNSForm 8.5 (EPT/RI)
12th Apr 20244:02 pmRNSForm 8.3 - CENTAUR MEDIA PLC
12th Apr 20243:21 pmRNSForm 8.3 - Centaur Media Plc
12th Apr 202412:59 pmRNSForm 8.3 - Centaur Media plc
12th Apr 202411:44 amRNSForm 8.3 - Centaur Media PLC
12th Apr 202410:55 amRNSForm 8.5 (EPT/RI) - Centaur Media PLC
12th Apr 202410:14 amRNSForm 8.3 - Centaur Media Plc
12th Apr 20248:12 amGNWForm 8.5 (EPT/RI) - Centaur Media
11th Apr 20243:15 pmPRNForm 8 (OPD) - Centaur Media plc
11th Apr 202412:21 pmRNSForm 8.3 - Centaur Media plc
11th Apr 202411:25 amRNSForm 8.3 - Centaur Media plc
11th Apr 202411:08 amGNWForm 8.3 - [ CENTAUR MEDIA PLC - Opening Disclosure - 10 04 2024] - (CGAML)
11th Apr 202410:45 amRNSForm 8.5 (EPT/RI)
11th Apr 20246:57 amGNWForm 8.5 (EPT/RI) - Centaur Media plc
10th Apr 202412:53 pmRNSStatement re Possible Offer for Centaur Media Plc
3rd Apr 20243:00 pmRNSAnnual Report 2023 and Associated Documents
28th Mar 20247:03 amRNSNotification of Capital Markets Day
25th Mar 20245:55 pmRNSHolding(s) in Company
20th Mar 20244:14 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
20th Feb 202410:49 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTrading Update
19th Dec 202311:25 amRNSDirector/PDMR Shareholding
20th Nov 202311:22 amRNSDirector/PDMR Shareholding
26th Oct 20234:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20239:30 amRNSDirector/PDMR Shareholding
20th Sep 20232:51 pmRNSDirector/PDMR Shareholding
19th Sep 202311:22 amRNSDirector/PDMR Shareholding
25th Aug 202311:00 amRNSDirector/PDMR Shareholding
21st Aug 202310:40 amRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSInterim Results
17th Jul 20233:43 pmRNSDirector/PDMR Shareholding
21st Jun 20233:28 pmRNSDirector/PDMR Shareholding
1st Jun 202311:18 amRNSDirector Declaration
31st May 20234:35 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.